Our study reveals that risperidone treatment in mice causes weekly body weight gain and changes in body weight, fat tissue weight, fatty liver disease, food efficiency, ALT and AST serum levels, serum and hepatic triglyceride levels, adipocyte size, and renal pathology. Here, GPT is linked to fatty liver disease.